首页> 外国专利> RECOMBINANT PLASMID DNA PUABC 22 ENCODING MODIFIED ACTIVATOR OF URICASE TYPE PLASMINOGEN, NONTRANSLATED DNA-ELEMENT - ARTIFICIAL INTERGENE SEQUENCE MGP-14 AND STRAIN OF BACTERIUM ESCHERICHIA COLI - PRODUCER OF MODIFIED ACTIVATOR OF URICASE TYPE PLASMINOGEN

RECOMBINANT PLASMID DNA PUABC 22 ENCODING MODIFIED ACTIVATOR OF URICASE TYPE PLASMINOGEN, NONTRANSLATED DNA-ELEMENT - ARTIFICIAL INTERGENE SEQUENCE MGP-14 AND STRAIN OF BACTERIUM ESCHERICHIA COLI - PRODUCER OF MODIFIED ACTIVATOR OF URICASE TYPE PLASMINOGEN

机译:编码尿素酶型纤溶酶原的修饰激活子的重组质粒DNA PUABC 22,非翻译DNA元素-人工内序列MGP-14和大肠杆菌细菌菌株的菌株-尿素酶纤溶酶的修饰激活子的生产者

摘要

FIELD: genetic engineering, biotechnology. SUBSTANCE: invention relates to biotechnology of preparing highly productive strains of Escherichia coli - producers of human recombinant proteins used in the modern medicine as thrombolytic agents. New recombinant plasmid DNA pUABC 22 encoding the modified activator of plasminogen of uricase type (mAPUT) has a size 4.5 t. n. p. and has the following components: XmnI-Bam HI-fragment of DNA of plasmid pUABC 22 (size is 2.99 t. n. p.); Bam HI-KpnI-fragment of DNA (size is 0.177 t. n. p.) containing the site of encoding region of gene mAPUT and corresponding to 12 C-terminal amino acids of mAPUT and nontranslated element - an artificial intergene sequence MGP-14; KpnI-SacI-fragment of DNA (size is 0.57 t. n. p.) containing gene tRNA Arg; SacI-XnmI-fragment of DNA of vector pUC 19 (size is 0.79 t. n. p.); site of replication initiation and promoter-operator region of lac-operon; genetic markers; gene determining the resistance to ampicillin. Nontranslated DNA-elements - an artificial intergene sequence MGP-14 and gene tRNA Arg enhance the total stability of the expression system of mAPUT in Escherichia coli cells and enhance its translating activity with respect to eucaryotic genes. The new strain VKPM B-7666 produces 3.0 g cellular biomass/1 l of cultural fluid and produces mAPUT in an proenzyme form mainly (molecular mass is 43 kDa) at amount 200 000-250 000 U/1 g of biomass. EFFECT: new strain indicated above, increased yield of the plasminogen activator. 4 cl, 4 dwg, 4 ex
机译:领域:基因工程,生物技术。物质本发明涉及制备高产大肠杆菌菌株的生物技术-在现代医学中用作溶栓剂的人重组蛋白的生产者。编码尿酸酶型纤溶酶原激活剂(mAPUT)的新型重组质粒DNA pUABC 22的大小为4.5 t。 。 p。并具有以下成分:质粒pUABC 22的DNA的XmnI-Bam HI-片段(大小为2.99 t。n。p。); DNA的Bam HI-KpnI片段(大小为0.177 t。n。p。),包含基因mAPUT的编码区,并对应于mAPUT的12个C末端氨基酸和非翻译元件-人工基因间序列MGP-14;含有基因tRNA Arg的DNA的KpnI-SacI片段(大小为0.57 t。n。p。);载体pUC 19的DNA的SacI-XnmI片段(大小为0.79t.n.p.); lac操纵子的复制起始位点和启动子-操纵子区域;基因标记该基因决定了对氨苄西林的耐药性。非翻译的DNA元件-人工基因间序列MGP-14和基因tRNA Arg增强了mAPUT在大肠杆菌细胞中表达系统的总体稳定性,并增强了其相对于真核基因的翻译活性。新菌株VKPM B-7666产生3.0 g细胞生物质/ 1 l培养液,并主要以酶原形式(分子质量为43 kDa)产生mAPUT,量为200 000-250 000 U / 1 g生物质。效果:上述新菌株可增加纤溶酶原激活剂的产量。 4 cl,4 dwg,4 ex

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号